SpecGx, LLC: Drug Recall
Recall #D-0255-2026 · 12/16/2025
Class II: Risk
Recall Details
- Recall Number
- D-0255-2026
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- SpecGx, LLC
- Status
- Ongoing
- Date Initiated
- 12/16/2025
- Location
- Webster Groves, MO, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 74,544 bottles
Reason for Recall
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Product Description
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Distribution Pattern
Nationwide
Other Recalls by SpecGx, LLC
- Class II: Risk 12/16/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.